TOIIW
The Oncology Institute, Inc.
NASDAQ · Healthcare · Medical - Care Facilities · US
$0.05
−3.27%Year over year
Reported trailing growth
- Revenue
- +38.4%
- EBITDA
- +54.7%
- EBIT
- +44.4%
- EPS
- +54.5%
- Free cash flow
- +74.9%
- Operating cash flow
- +103.2%
Forward estimates
Based on analyst estimates
- Revenue
- —
- EBITDA
- —
- EPS
- —
Three-year CAGR
- Revenue
- +25.8%
- EBITDA
- +16.4%
- EBIT
- +40.0%
- Net income
- +6.3%
- EPS
- +23.9%
- Free cash flow
- +8.4%
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Jun 1, 2026